SNY has been in the news 375% more than usual
Sep 04, 2025, 8:31 PM
12.22%
What does SNY do
It seems that the content you want summarized is not provided. Please share the text or details you'd like summarized, and I'll be happy to help!
SNY has been in the news recently: Sanofi SA's stock experienced a significant decline following disappointing trial results for amlitelimab, causing concerns about the company's dermatology franchise after the Dupixent patent expiration. In contrast, Nektar Therapeutics Inc. saw an increase in its stock, with trading volume exceeding its average.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.